Protosource Corporation (PSCO)
OTHER OTC:PSCO
US Market
Holding PSCO?
Track your performance easily

Protosource (PSCO) Income Statement

0 Followers

Protosource Income Statement

Last quarter (Q ), Protosource's total revenue was $706.59K, a decrease of -23.09% from the same quarter last year. In Q, Protosource's net income was $-103.49K. See Protosource’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 08Dec 07Dec 06Dec 05Dec 04
Total Revenue
$ 34.92M$ 35.36M$ 3.13M$ 2.64M$ 1.94M$ 1.64M
Cost of Revenue
$ 2.40M$ 2.64M$ 1.94M$ 1.64M$ 1.06M$ 916.73K
Gross Profit
$ 32.52M$ 32.72M$ 1.18M$ 1.00M$ 882.51K$ 722.87K
Operating Expense
$ 32.79M$ 32.91M$ 1.09M$ 968.14K$ 789.43K$ 928.75K
Operating Income
$ -267.88K$ -190.94K$ 91.25K$ 36.12K$ 93.08K$ -205.88K
Net Non Operating Interest Income Expense
$ -357.07K-----
Other Income Expense
$ -69.96K$ 11.48K$ -571.03K$ -6.57K$ -227.39K$ -16.78K
Pretax Income
------
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -701.49K$ -625.38K$ -874.10K$ -303.70K$ -495.87K$ -1.23M
Basic EPS
$ -0.02$ -0.02$ -0.03$ -0.01$ -0.02$ -0.04
Diluted EPS
$ -0.02$ -0.02$ -0.03$ -0.01$ -0.02$ -0.04
Basic Average Shares
$ 131.50M$ 32.87M$ 32.87M$ 32.87M$ 32.87M$ 31.80M
Diluted Average Shares
$ 131.50M$ 32.87M$ 32.87M$ 32.87M$ 32.87M$ 31.80M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 35.19M$ 35.55M$ 3.03M$ 2.61M$ 1.85M$ 1.85M
Net Income From Continuing And Discontinued Operation
$ -701.49K$ -625.38K$ -874.10K$ -303.70K$ -495.87K$ -1.23M
Normalized Income
$ -631.52K$ -636.86K$ -303.07K$ -297.13K$ -268.48K$ -1.69M
Interest Expense
$ 357.07K-----
EBIT
$ -267.88K$ -190.94K$ 91.25K$ 36.12K$ 93.08K$ -205.88K
EBITDA
$ -200.16K$ -107.00K$ 168.48K$ 89.52K$ 225.72K$ 720.50K
Currency in USD

Protosource Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis